M. Ruffelli

712 total citations
14 papers, 466 citations indexed

About

M. Ruffelli is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, M. Ruffelli has authored 14 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Rheumatology and 6 papers in Genetics. Recurrent topics in M. Ruffelli's work include Autoimmune Bullous Skin Diseases (7 papers), Urticaria and Related Conditions (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). M. Ruffelli is often cited by papers focused on Autoimmune Bullous Skin Diseases (7 papers), Urticaria and Related Conditions (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). M. Ruffelli collaborates with scholars based in Italy, United Kingdom and India. M. Ruffelli's co-authors include Alessandra Frezzolini, Pietro Puddu, Giuseppe Cianchini, O. De Pità, Rosamaria Corona, Biagio Didona, Giovanni Di Zenzo, M. Paradisi, Giovanna Zambruno and Patrizia Teofoli and has published in prestigious journals such as Journal of Investigative Dermatology, British Journal of Dermatology and Allergy.

In The Last Decade

M. Ruffelli

14 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ruffelli Italy 11 303 251 236 83 80 14 466
Clive Grattan United Kingdom 7 393 1.3× 773 3.1× 380 1.6× 214 2.6× 245 3.1× 13 1.0k
Massimo Drosera Italy 10 154 0.5× 201 0.8× 80 0.3× 28 0.3× 111 1.4× 15 319
Salvatore Lupoli Italy 8 200 0.7× 106 0.4× 19 0.1× 56 0.7× 101 1.3× 12 339
Hakan M. Gürcan United States 12 332 1.1× 244 1.0× 238 1.0× 17 0.2× 141 1.8× 12 582
M. Hamidou France 10 131 0.4× 113 0.5× 155 0.7× 13 0.2× 188 2.4× 24 493
Yoshie Kawahara Japan 11 342 1.1× 306 1.2× 312 1.3× 29 0.3× 6 0.1× 25 501
Andrew Chubick United States 6 127 0.4× 269 1.1× 143 0.6× 10 0.1× 154 1.9× 8 456
Peter Y. Chang United States 11 115 0.4× 168 0.7× 88 0.4× 8 0.1× 38 0.5× 33 479
H Elling Denmark 12 43 0.1× 244 1.0× 105 0.4× 15 0.2× 77 1.0× 28 439
Ivo Jajić Croatia 8 112 0.4× 276 1.1× 50 0.2× 9 0.1× 50 0.6× 30 407

Countries citing papers authored by M. Ruffelli

Since Specialization
Citations

This map shows the geographic impact of M. Ruffelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ruffelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ruffelli more than expected).

Fields of papers citing papers by M. Ruffelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ruffelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ruffelli. The network helps show where M. Ruffelli may publish in the future.

Co-authorship network of co-authors of M. Ruffelli

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ruffelli. A scholar is included among the top collaborators of M. Ruffelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ruffelli. M. Ruffelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sinistro, Anna, Valentina Calabresi, Francesca Lupi, et al.. (2015). The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris. European Journal of Dermatology. 25(6). 578–585. 6 indexed citations
2.
Ruffelli, M., et al.. (2007). Oral Allergic Syndrome and Recombinant Allergens rBet v 1 and rBet v 2. European Journal of Inflammation. 5(1). 21–25. 11 indexed citations
3.
Cianchini, Giuseppe, Rosamaria Corona, Alessandra Frezzolini, et al.. (2007). Treatment of Severe Pemphigus With Rituximab. Archives of Dermatology. 143(8). 1033–8. 109 indexed citations
4.
Zenzo, Giovanni Di, et al.. (2006). The Intracellular and Extracellular Domains of BP180 Antigen Comprise Novel Epitopes Targeted by Pemphigoid Gestationis Autoantibodies. Journal of Investigative Dermatology. 127(4). 864–873. 45 indexed citations
5.
Mariotti, Feliciana, M. Ruffelli, Paola Cordiali‐Fei, et al.. (2004). Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. British Journal of Dermatology. 151(5). 1004–1010. 61 indexed citations
6.
Frezzolini, Alessandra, et al.. (2004). Interleukin-16 expression and release in bullous pemphigoid. Clinical & Experimental Immunology. 137(3). 595–600. 36 indexed citations
7.
Puddu, Paolo Emilio, et al.. (2003). An Open Randomized Controlled Study on the Efficacy of Low-Sodium Water Intake Evaluated by Non-Invasive Methods in Patients with Cellulite. European Journal of Inflammation. 1(1). 43–48. 1 indexed citations
8.
9.
Frezzolini, Alessandra, Patrizia Teofoli, Giuseppe Cianchini, et al.. (2002). Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.. PubMed. 12(1). 27–31. 40 indexed citations
10.
Frezzolini, Alessandra, et al.. (1999). Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention. Allergy. 54(5). 507–510. 15 indexed citations
11.
Pità, O. De, Alessandra Frezzolini, Giuseppe Cianchini, et al.. (1997). T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30). Archives of Dermatological Research. 289(12). 667–670. 27 indexed citations
12.
Frezzolini, Alessandra, et al.. (1997). Soluble CD30 in pediatric patients with atopic dermatitis. Allergy. 52(1). 106–109. 48 indexed citations
13.
Pità, O. De, et al.. (1996). Psoriasis: comparison of immunological markers in patients with acute and remission phase. Journal of Dermatological Science. 13(2). 118–124. 21 indexed citations
14.
Puddu, Pietro, et al.. (1996). Intravenous immunoglobulin therapy: Modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus. Arthritis & Rheumatism. 39(4). 704–705. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clive Grattan Breakdown of academic impact, for papers by Massimo Drosera Breakdown of academic impact, for papers by Salvatore Lupoli Breakdown of academic impact, for papers by Hakan M. Gürcan Breakdown of academic impact, for papers by M. Hamidou Breakdown of academic impact, for papers by Yoshie Kawahara Breakdown of academic impact, for papers by Andrew Chubick Breakdown of academic impact, for papers by Peter Y. Chang Breakdown of academic impact, for papers by H Elling Breakdown of academic impact, for papers by Ivo Jajić
Rankless by CCL
2026